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The  kallikrein–kinin  system  (KKS)  has  been  described  as  an  important  mediator  of physiologic  processes.
Kallikreins  use  kininogen  (KNG)  as  substrate  to generate  bradykinin,  the  main  active  peptide  of  the  KKS
that  acts through  two types  of  receptors,  the  B1R and  the  B2R.  The  goal  of  this  study  was  to  characterize
some  components  of  the  KKS  in different  compartments  of the  ovary  during  the  bovine  ovulation  process.
The  KNG,  B1R and  B2R mRNA  expression  patterns  were  assessed  in  theca  and  granulosa  cells, as  well  as  the
bradykinin  concentration  and  kallikrein-like  activity  in follicular  ﬂuid  of  bovine  periovulatory  follicles.  To
obtain  a  periovulatory  follicle  (≥12  mm),  twenty-seven  cows  were  submitted  to estrus  synchronization
protocol  and  ovariectomized  by colpotomy  at 0,  3, 6, 12  or 24  h after  a  GnRH-analog  injection  (gonadore-
lin;  100  g,  IM).  Follicular  ﬂuid  was  aspirated  for enzymatic  assays  while  granulosa  and  theca  cells  were
harvested  for  mRNA  analysis.  The  mRNA  expressions  in  follicular  cells  were  evaluated  by real-time  RT-PCR
and  data  representation  related  to the cyclophilin  housekeeping  gene.  The  bradykinin  concentration  and
kallikrein-like  activity  were  measured  in follicular  ﬂuid  by  enzymatic  immunoassay  and selective  sub-
strate  cleavage,  respectively.  The  B2R expression  in  theca  cells  and  B1R  expression  in  theca  and  granulosa
cells  showed  different  proﬁles  during  the periovulatory  period  (P  <  0.05).  The  bradykinin  concentration
and  kallikrein-like  activity  in the follicular  ﬂuid  were  different  (P  < 0.05)  due to  the  time  during  the  ovu-
lation  process.  KNG  mRNA  expression  was  similar  for  both  follicular  cell  types  (P >  0.05).  Taken  together,
these  results  provide  an important  characterization  of  the  presence  and  possible  KKS  regulation  during
the  bovine  ovulation.. Introduction
Ovulation is characterized as a sequence of events in a respon-
ive preovulatory follicle after a luteinizing hormone (LH) surge
12,28]. This event is controlled by a complex interaction of factors,
ncluding endocrine mechanisms, cellular messengers, proteases,
inases and activating enzymes and has been compared to an
nﬂammatory response [12,28].
The kallikrein–kinin system (KKS) is an important mediator
f inﬂammatory responses acting on vasodilatation, activa-
ion and inactivation of proteases, stimulation of prostaglandin
iosynthesis as well as induction of smooth muscle contractility
∗ Corresponding author at: Universidade Federal de Santa Maria, Programa de Pós-
raduac¸ ão em Medicina Veterinária, Av. Roraima 1000, Santa Maria, RS 97105-900,
razil.  Tel.: +55 55 3311 6073; fax: +55 11 4043 6428.
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Open access under the Elsevier OA license.© 2011  Elsevier  Inc.  
[3,24]. Kininogen (KNG) is a precursor protein of the KKS; plasma
kallikrein uses KNG as a substrate to generate bradykinin while
tissue kallikrein liberates kallidin that is cleaved to the bradykinin
[3,11]. Bradykinin is a nonapeptide kinin, the main mediator of KKS
responses [3,8]. This system acts through two  types of receptors,
type 1 (B1R) and type 2 receptor (B2R). Therefore, the ovulation
resembles an inﬂammatory process and the KKS is involved in
the inﬂammatory function. This system has been suggested as a
possible important mediator of the ovulatory process [5,16–18].
Despite  the increasing evidences on the role of the KKS in
mammal  ovaries, little is known about the regulation of these
components at distinct ovarian compartments, mainly in monovu-
latory species. Additionally, the intrafollicular factors that initiate
and control the ovulatory process are not well understood [13].
Open access under the Elsevier OA license.Thus, the knowledge on this system role during the ovulatory pro-
cess can allow a better control of physiological functions to be
applied to reproduction biotechnology and infertility treatments.
The purpose of this study is to characterize the presence and
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egulation of some of the KKS components during the bovine ovu-
ation process.
. Material and method
.1. Animals and experimental design
Twenty-seven cyclic beef cows were pre-synchronized to obtain
 GnRH responsive follicle (≥12 mm;  [30]) at the beginning of the
xperiment according to a previous study [13]. Brieﬂy, females that
ad ≥12 mm pre-ovulatory follicles on Day 10, were administered
nRH analog (Gonadorelin, 100 g IM,  Profertil®, Tortuga, Brazil)
nd the ovaries were removed 0, 3, 6, 12 and 24 h after the GnRH,
y colpotomy in standing position [10]. After the ovariectomy, fol-
icular ﬂuid, granulosa and theca cells were collected and stored
onform described ﬁrst [29]. All procedures involving animals per-
ormed in this experiment were approved by the Ethics and Animal
elfare Committee, Universidade Federal de Santa Maria, protocol
umber 23081.007716/2010-61.
.2. Nucleic acid extraction and real-time RT-PCR
Total RNA was extracted using Trizol (theca cells) or silica based
rotocol (granulosa cells; Qiagen, Mississauga, Canada) accord-
ng to the manufacturer’s instructions and was quantiﬁed by
bsorbance at 260 nm.  Total RNA (1 g) was ﬁrst treated with 0.2 U
Nase (Invitrogen, Brazil) at 37 ◦C for 5 min, to digest any contami-
ating DNA, and then heated to 65 ◦C for 3 min. The RNA was  reverse
ranscribed (RT) in the presence of 1 M oligo(dT), primer, 4 U
mniscript RTase (Omniscript RT Kit; Qiagen, Mississauga, Canada),
.5 M dideoxynucleotide triphosphate (dNTP) mix  and 10 U RNase
nhibitor (Invitrogen, Brazil) in a volume of 20 L at 37 ◦C for 1 h.
he reaction was terminated by incubation at 93 ◦C for 5 min.
The Real-time polymerase chain reaction (PCR) was  conducted
n a Step One Plus instrument (Applied Biosystems, Foster City,
anada) with Platinum SYBR Green qPCR SuperMix (Invitro-
en, Brazil) and bovine-speciﬁc primers KNG (Initiator sense:
TGGCTGTGTGCATCCCATA and anti-sense:  AGGTGGGAATGACTG-
TGTTG); B2R (Initiator sense: TCACCAACATCCTCCTGAACTCT and
nti-sense:  CGTGGCCTTCCTCTCAGTCT); and B1R (Initiator sense:
TCGACGGCGTCTGAACAC and anti-sense:  CGGATGTTCTCTGCCCA-
AA). Common thermal cycling parameters (3 min  at 95 ◦C, 40
ycles of 15 s at 95 ◦C, 30 s at 60 ◦C, and 30 s at 72 ◦C) were used to
mplify each transcript. Melting-curve analyses were performed to
erify the product identity. Samples were run in duplicate and were
xpressed relative to cyclophilin as the housekeeping gene. The
elative quantiﬁcation of gene expression across treatments was
valuated using the ddCT method [22]. Brieﬂy, the dCT is calculated
s the difference between the CT of the investigated gene and the CT
f housekeeping gene in each sample. The ddCT of each investigated
ene is calculated as the difference between the dCT in each treated
ample and the dCT of the sample with lower gene expression
higher dCT). The fold change in relative mRNA concentrations was
alculated using the 2−ddCT formula. Bovine-speciﬁc primers were
aken from literature or designed using Primer Express Software
3.0 (Applied Biosystems, USA) and synthesized by Invitrogen,
anada. The cross-contamination in granulosa and theca cells were
ested by Real-time PCR conform ﬁrst described [7,29].
.3. Kallikrein-like activity, kinin and estradiol levels in the
ollicular ﬂuidThe activity of a tissue kallikrein-like enzyme was  measured
n the selective peptide-nitroanilide substrate d-Val-Leu-Arg-
aranitroaniline (d-Val-Leu-Arg-pNA, dissolved in ultrapure water
o a concentration of 1.5 mM and stored at 4 ◦C). The method used (2011) 2122–2126 2123
for measurement of the kallikrein tissue was the same as the previ-
ously described [27] one, but with some modiﬁcations. The protein
content of the follicular ﬂuid was  determined by the Bradford
method [4],  using a standard curve with known concentrations of
bovine serum albumin within the absorbance reference. The results
of the kallikrein enzyme activity were expressed as nmol of the
formed product (p-nitroaniline) by time (in minutes) and also by
amount of protein (expressed in mg  of protein) of each follicular
ﬂuid sample [27].
The bradykinin enzyme was  measured by enzyme immunoas-
says, using a high-sensitivity kit for bradykinin (Bachem, USA),
according to the manufacturer’s protocol. Absorbance was read
at 450 nm (measured in a Plate reader, Bioteck, USA), using
100 l of TMB  solution and 100 l 2 N HCl as a blank control.
Manufacturer’s information shows that the kit anti-bradykinin
anti-body reacts with bradykinin, kallidin, [Des-Arg1]-bradykinin
and biotinyl-bradykinin and this peptides detection limit is of
approximately 0.004 ng/ml.
The follicular ﬂuid was  assayed using enzyme-linked
immunosorbent assay (ELISA), to determine estradiol concen-
tration, following the manufacturer’s instructions (Cayman
Biochemical).
2.4. Statistical analysis
The differences on continuous data between hours during the
ovulation process were accessed by analysis of variance (ANOVA)
and multi-comparison between hours was  performed by least
square means. Data were tested for normal distribution using the
Shapiro–Wilk test and normalized when necessary. All analyses
were performed using the JMP  software (SAS Institute Inc., Cary,
USA) and a P < 0.05 was considered statistically signiﬁcant. Data
are presented as mean ± sem.
3. Results
3.1. The ovulation process model
There were no differences regarding follicular diameter in dif-
ferent time-points before the ovariectomy (evaluated through
ultrasound; data not shown). The concentration of estradiol
increased 3 h after treatment with GnRH, the expected endogenous
LH surge time, and gradually decreased thereafter, up to 24 h (data
not shown).
3.2. Gene expression of KNG, B1R and B2R in follicular cells
The KKS precursor expression, or KNG, was similar for both
follicular cell types, granulosa and theca, during the ovulation
(P > 0.05, Fig. 1A and B). The mRNA expression of the B2R recep-
tor was  constant during the ovulation process in granulosa cells,
with no difference (P > 0.05) at different times after the LH surge
induction (Fig. 1C). However, in theca cells, the mRNA B2R receptor
expression showed an increase (P < 0.05) after the GnRH (hour zero)
injection up until 6 h and gradual decrease at 12 h, remaining con-
stant until 24 h (Fig. 1D). The B1R receptor mRNA expression was
different in both follicular cells types during the assessed times.
In granulosa cells (Fig. 1E), the expression increased only at 6 h
and decreased after that. In theca cells (Fig. 1F), the B1R expres-
sion increased at 3 and 6 h, decreased at 12 h and then remained
constant until 24 h.3.3. Kallikrein and bradykinin follicular ﬂuid concentration
Results for kallikrein-like activity in the follicular ﬂuid showed
a decrease (P < 0.05) between the LH ovulatory surge induction
2124 G.F. Ilha et al. / Peptides 32 (2011) 2122–2126
Fig. 1. mRNA expression of the KNG (A and B), B2R (C and D) and B1R (E and F) in follicular cells, granulosa and theca, relative to cyclophilin housekeeping. To obtain a
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ere-ovulatory bovine follicle (>12 mm),  the animals were pre-synchronized and the
etters indicates statistical difference (P < 0.05).
hour zero) and 24 h (Fig. 2A). There was, however, no differ-
nce between zero and 12 h. The bradykinin presented differences
P < 0.05) during the ovulation. The BK increased after zero hour
ntil 6 h, decreased until 12 h and remained constant up until 24 h
Fig. 2B).
. DiscussionThis study demonstrated for the ﬁrst time that components
f the KKS system are produced in the ovary during ovulation in
onovular species, using a sensitive semi-quantitative RT-PCR and
nzymatic assay for the KKS components. Our results support thelar cells were collected in different times after the GnRH analog injection. Different
fact that the KNG is synthesized in the ovary, in different follicular
cells types and in follicular ﬂuid, after the LH surge induction up
until the moment preceding cattle ovulation. An in vivo approach
to study the bovine ovulation was used. The species, in contrast
with rodents, is a great monovulatory model and has a wide period
between the LH surge and the ovulation, from 24 to 30 h.
Previous studies did not make clear if the KKS is synthesized in
the ovary or if it has an hepatic origin and an unknown mechanism
would be responsible for moving such compounds into the folli-
cles [17]. There are at least two  distinct kininogens in mammalian
plasma, designated low molecular weight (LMWK) and high molec-
ular weight (HMWK) kininogens and it was  indicated that LMWK
and HMWK  are structurally related [19]. Both HMWK and LMWK
G.F. Ilha et al. / Peptides 32
Fig. 2. The kallikrein activity (nmol/mg protein/min, A) and bradykinin (ng/mg pro-
tein, B) in the follicular ﬂuid in pre-ovulatory follicles. To obtain a pre-ovulatory
bovine follicle (>12 mm),  the animals were pre-synchronized and the follicular ﬂuid
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has a possible low regulation while bradykinin has a high regula-as  collected in different times after the GnRH analog injection. Different letters
ndicates statistical difference (P < 0.05).
ave an identical aminoacid sequence starting named heavy chain
19,24]. On this study, the primer used to assess mRNA expression
or total KNG was designed based on the sequence of the heavy
hain. The total KNG, both LMWK  and HMWK  kininogens, in differ-
nt follicular cells were no different at different times during bovine
vulation (Fig. 1A and B). However, during the follicular develop-
ent, mature tertiary follicles of cultured bovine granulosa cells
howed highest KNG than immature follicles [26]. On the other
and, in rats, the total ovarian KNG levels showed a progressive
ise immediately before the beginning of ovulation [5,14].
Kallikreins are serine proteases that use KNG by substrate to
enerate kallidin and bradykinin, and are members of a multigene
amily in several species [9].  This family of enzymes are involved in
 diverse range of biological responses [16] and holds great promise
ot just as a panel of biomarkers and potential therapeutic targets,
ut also as an important model of hormonal regulation [20]. The
xpression and hormonal regulation of the tissue kallikrein gene
amily in the rat was previously extensively characterized [9].  Pre-
allikrein and kallikrein have been described in cultured bovine
ranulosa cells of immature follicles cells and mature follicles cells,
espectively [26]. In this study, kallikrein was identiﬁed in the follic-
lar ﬂuid, conﬁrming the hypothesis that this enzyme participates,
nd probably regulates, in cattle ovulatory process (Fig. 2A). Our
esults suggest a similarity in the kallikrein activity during ovula-
ion in rats and cattle [14,16]. (2011) 2122–2126 2125
Bradykinin, the main peptide of KKS, is present in the follicular
ﬂuid and has an high regulation after the GnRH treatment, reaching
the surge at 6 h and decreasing after that, during the bovine ovula-
tion process (Fig. 2B). Bradykinin is a nonapeptide kinin, potent
mediator of a wide variety of KKS responses [3,8]. This peptide
induces ovulation in perfused rabbit [32] and rat ovaries [15], and
potentiates the action of the LH [6].  There are evidences that this
peptide is involved in follicular-wall contraction during the ovu-
lation [15]. Other studies demonstrated that, when using porcine
ovaries, not only all components of the KKS, but also its product,
bradykinin, are present within the follicles [17]. This study showed
the presence of bradykinin in the follicular ﬂuid, but more studies
have to be done in order to clarify the importance of this kinin in
bovine reproduction.
Bradykinin is known to be degraded rapidly in vivo, with a
half-life of about 16 s [2].  The main peptidase capable of metaboliz-
ing kinins is the angiotensin I-converting enzyme (ACE). Moreover
many others peptidases have been reviewed [11], including the
aminopeptidase P, neutral endopeptidase 24.11 (NEP, neprilysin),
and carboxypeptidases M and N [24]. They are all present in a
soluble form in biologic ﬂuids depending on the animal species,
according to the analytical approach, the biological milieu and the
pathophysiological context [24]. Using similar ovulation exper-
imental models, our group recently showed that ACE mRNA
expressions were transiently high, and then regulated, reaching
greater expression 6 h after the GnRH treatment in theca, but
not in granulosa cells (Siqueira et al., manuscript in prepara-
tion). On the other hand, the mRNA expression of NEP increased
12 and 24 h after the GnRH treatment in granulosa cells, but
not in theca cells [29]. These results show that these pepti-
dases can participate of the bradykinin down regulation in bovine
follicles.
The expression of the KKS receptors in different follicular cell
types showed that the B1R was induced in both follicular cells
types while the B2R was  constitutively expressed in granulosa cells
(Fig. 1E and F) and possibly induced in theca cells (Fig. 1D and E).
These two  types of G-protein-coupled receptors mediate the cellu-
lar effects of kinins [21,23].  The effects of bradykinin and kallidin
are believed to be mediated particularly in the B2R [3,23]. Whereas
the B1R mediates the action of des-Arg9-BK and Lys-des-Arg9-BK,
the second set of bioactive kinins are formed through the actions
of carboxypeptidases on bradykinin and kallidin, respectively [21].
These receptors are expressed under biologically different circum-
stances [23]. The B2R is constitutively expressed on many cell types
and is responsible for the majority of the observed effects of kinins.
However, the B1R is induced only in inﬂammation [1,26]. At repro-
ductive events, little is known about the participation of B1R [1],
while some researchers have been studying B2R [17,18,25,26,31].
The presence of B2R is different in various species [17], and the
expression is constant in theca and granulosa porcine cells and in
mouse ovaries [18,25]. The results of our study, besides highlight-
ing the difference of B2R expressions in different species, show that
there are B1R and B2R expressions in theca and granulosa cells in
bovine ovary, demonstrating that the expression patterns are dif-
ferent in the two follicular cells types. Moreover, for the ﬁrst time, it
demonstrated that the expression of B1R in both follicular cells and
B2R in theca cells can be regulated during cattle ovulation. Based
on these results, it is possible to postulate a feasible regulation of
these KKS receptors at ovulation in cattle.
This study, using an in vivo approach, conﬁrms the presence of
some components of the KKS during the bovine ovulation. Accord-
ing to our results, the KNG is synthesized in the ovary and kallikreintion, decreasing after that. We  show that there are B1R and B2R
expressions in theca and granulosa cells, demonstrating that the
expression patterns between the two follicular cells types, and in
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